Is It Overvalued? Look at the P/S Ratio: Xilinx Inc. (XLNX), CounterPath Corporation (CPAH)

You should consider shares of Xilinx Inc. (NASDAQ:XLNX) and CounterPath Corporation (NASDAQ:CPAH) if you are looking for a great stocks to invest in. Starting with the XLNX shares, which traded at $98.83 at the close of the recent session, dropping -0.78%. On Wednesday, the company’s shares shed -$0.78 from its value which represented in intraday trading. The stock is now 1.08% higher in year-to-date (YTD) trading. XLNX’s intraday high was $99.86 while its lowest price touched $97.90. The stock’s 52-week high price is $141.60, which means the current price is at -30.20%. In terms of trading activity, the daily trading volume fell to 2597295 against 200-day average trading volume of 3,539,368 shares.

What are analyst forecasts for Xilinx Inc. (NASDAQ:XLNX)?

At a consensus rating of 3.33, XLNX is trending as a streaking Hold, as it has been the case a month ago when 19 analysts called it a Moderate Buy. Two months ago, 19 analysts recommended, on average, that XLNX stock is a Moderate Buy. The Technology company’s shares’ overall bearish trend saw it close higher on Wednesday compared to its opening price of $99.50 on the day.

Forecasts for Xilinx Inc. (NASDAQ:XLNX) give the stock a fair value for the growth of 5.88% from its last price. The 12-month price forecast for the stock by analysts puts the stock’s mean price target at $105.00, which means the price per share could rise by nearly $6.17. The price range target is between a low of $88.00 and a high of $165.00. The stock would need to gain by about $40.1 to hit the estimated high or 0.89% from its 12-month low.

The consensus among 27 analysts is that it is a good time for one to Overweight in the Xilinx Inc. 10 analysts rate XLNX as a Buy, with 1 of 27 analysts rate it as a Sell. 1 have valued the stock as Overweight and 14 have recommended that investors Hold.

Xilinx Inc. (NASDAQ:XLNX) Upgrades and Downgrades

In terms of rating changes, BofA/Merrill on January 10, 2020, Downgrade Xilinx Inc. (XLNX) at Underperform. Analysts at Mizuho have assigned a Buy rating for the stock in their research note on October 24, 2019 with an estimated price target of $125. Moreover, Credit Suisse analysts issued a rating of Outperform for the stock on October 24, 2019, giving it a price target of $110 for the next 12 months. On October 24, 2019, the stock earned a Market Perform rating due to an analyst call from Cowen, while analysts from Citigroup on October 24, 2019 suggested that the stock is Neutral.

CounterPath Corporation (NASDAQ:CPAH) adds -$0.05 on Wednesday

The CPAH stock has risen 223.66% year-to-date and is currently trading at $3.01, which is -49.83% below its 52-week high. The company shares lost -1.63% on the day and have risen nearly 262.65% off a low hit. At current levels, CounterPath Corporation has a valuation of about $10.70M. As of 01/15/20, this stock has risen 198.02% during the week and closed at $3.06 in the previous session. However, recent CounterPath Corporation stock performance shows that CPAH shares are 204.04% up over the last month, and 164.04% up for the last three months.

Earnings per share (EPS) estimates for the current quarter are -$0.07, with the trailing 12-month share earnings at -$0.62. The ratio is expected to be up by 95.60% for the current year 2019 and 1,100.00% for next year. But will the CPAH stock surprise in the current quarter results, where the -$0.01 actual EPS reported on 10/30/2017 surprised by 92.30% or was higher by $0.12 from the estimated -$0.13.

Sales Growth to climb 15.10% for the year

How well will CounterPath Corporation perform as a business over the current quarter, year and next 5-year period? Compared to the year-ago quarter, analysts forecast the company to bring in between $3.8M and $3.8M in current quarter sales. The consensus estimated for the current quarter is $3.8M from sales. Forecasts for this fiscal year are between $14.6M and $14.6M and the consensus estimate for sales is at $14.6M.

Who owns shares in CounterPath Corporation (CPAH)?

Let’s briefly focus on the share ownership of the CounterPath Corporation (NASDAQ:CPAH) stock, where we find that 1.36% of shares are held by institutions. Wedbush Securities Inc tops the list of institutional owners as it is holding 28192.0 shares or 0.47% of shares outstanding. Geode Capital Management, LLC and Virtu Financial LLC held 17127.0 and 12646.0 representing 0.29% and 0.21% respectively at the close of the last trading session. As of Sep 29, 2019, Citadel Advisors LLC accounted for 12290.0 shares at over 14133.0. This represented 0.21% of shares outstanding. Acadian Asset Management held 5168.0 shares at over 5943.0 representing 0.09% of shares outstanding.

CPAH Insider Activity

Insider activity can also give a signal in terms of price direction. Looking at CounterPath Corporation (CPAH), a total of 11000 shares have been sold by insiders over the last 6 months while 2593 shares were added in the same time span.